Shukra Pharmaceuticals Ltd Stock Analysis

BSE: 524632 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 08-Feb-2023 18:01
69.60 3.30 (4.98%)

DeciZen - Make an Informed Decision on Shukra Pharma

M-Cap below 100cr DeciZen not available

Shukra Pharma Price Chart

P/E Ratio ( SA) :
69.53
Market Cap :
76.3 Cr.
52-wk low :
11.1
52-wk high :
69.6
Bole Toh?

1. Is Shukra Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shukra Pharmaceuticals Ltd is a below average quality company.

2. Is Shukra Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Shukra Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Shukra Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shukra Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Shukra Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shukra Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % -9.1%-6.3%-1.1%3.4%3.5%3.4%2.3%-0.2%0.7%4.2%-
Value Creation Index NA-1.5-1.1-0.8-0.8-0.8-0.8-1.0-1.0-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 5.14.42.64.85.15.35.711.911.220.522
YoY Gr. Rt. %--13.3%-41.8%87.2%6.4%3.9%6%109.4%-5.5%83%-
Adj EPS -0.2-1-0.20.70.70.70.6-0.10.211
YoY Gr. Rt. %-NANANA0%4.5%-12.9%-108.2%NA450%-
BVPS (₹) -0.118.418.618.719.42020.420.520.721.723.9
Adj Net Profit -1-0.8-0.20.50.50.50.500.10.71
Cash Flow from Ops. 10.4-3.1-22.7-0.30.80.31.20.57.8-
Debt/CF from Ops. 1-0.1-0.60-0.14.323.46.518.20.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 16.7%31.9%53.6%83%
Adj EPS NA8.1%17.5%450%
BVPS 02.32.14.8
Share Price 64.2% 44.7% 84.7% 406.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % -193.3-11.3-1.13.63.53.63-0.20.94.74.4
Op. Profit Mgn % 10.1-2.1-9.624.528.530.229.11312.914.115.2
Net Profit Mgn % -19.7-17-610.49.89.98.2-0.31.23.65
Debt to Equity -23.500.1000.20.40.50.60.20.1
Working Cap Days 601390879392379467526334487277273
Cash Conv. Cycle 1799016575643140391325431

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 4.40%

Sales growth is growing at healthy rate in last 3 years 53.55%

Net Profit is growing at healthy rate in last 3 years 17.52%

Sales growth is good in last 4 quarters at 53.06%

No data to display

Latest Financials - Shukra Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 1 -
TTM Sales (₹ Cr.) 22.1 -
BVPS (₹.) 23.9 -
Reserves (₹ Cr.) 15 -
P/BV 2.92 -
PE 69.53 -
From the Market
52 Week Low / High (₹) 11.14 / 69.60
All Time Low / High (₹) 0.09 / 66.30
Market Cap (₹ Cr.) 76.3
Equity (₹ Cr.) 11
Face Value (₹) 10
Industry PE 33.7

Management X-Ray of Shukra Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Shukra Pharma

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Shukra Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Shukra Pharma on 08-Feb-2023 18:01 is : 69.60.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 08-Feb-2023 18:01 the market cap of Shukra Pharma stood at ₹ 76.28.
The latest PE ratio of Shukra Pharma as of 08-Feb-2023 18:01 is 69.53.
The latest PB ratio of Shukra Pharma as of 08-Feb-2023 18:01 is 2.92
The 52-week high of Shukra Pharma is ₹ 69.60 and the 52-week low is ₹ 11.14.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Shukra Pharma is ₹ 22.11 ( Cr.) .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.

The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its stakeholders including customers, suppliers, employees and other interest groups by large. Shukra stands for uncompromising quality and efficiency to deliver proven solutions delivered by passionate and motivated team of individuals.

The company boasts fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. Along with internationally accredited facilities it invests in people.

The company has embarked upon its ambitious journey in the field of Pharamaceutical (date of inception) with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Since then, there was no looking back, within a short span of (years) the company has come a long way in making its mark in the sector.

The company has now developed an internationally accredited Laboratory in Ahmedabad where each product and solutions are developed under stringent quality processes.

Business area of the company

The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now